title: [Clinical-biochemical and immunological parameters in the diagnosis and treatment of chronic pyelonephritis on the background of intercurrent diseases].
abstract: Studies have shown that complicated chronic pyelonephritis in the active phase is characterized by structural and functional instability cytomembranes and decreased immunological resistance of the patient man. Supplement standard antibiotic treatment with ozone therapy antioxidant immunomodulation drug thus received immunobiochemical study.
authors: V I
authors: VI
authors: Ermishina
authors: N I
authors: NI
authors: Kazeko
authors: V B
authors: VB
authors: Berdichevskiĭ
authors: Sh S
authors: ShS
authors: Mendelian
authors: S Zh
authors: SZh
authors: Il'iasov
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D005260:Female; D006801:Humans; D055633:Immune System Phenomena / Q000187:drug effects; D015227:Lipid Peroxidation / Q000187:drug effects; D008165:Luminol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010126:Ozone / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000097:blood / Q000150:complications / Q000276:immunology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000975:Antioxidants; D008165:Luminol; D010126:Ozone; C511308:sodium luminolate